EUR 5.8
(-1.36%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.00 EUR | 100.0% |
2022 | -469 Thousand EUR | 0.0% |
2021 | - EUR | -100.0% |
2020 | 1.00 EUR | -100.0% |
2019 | 3.2 Million EUR | 220.96% |
2018 | 997 Thousand EUR | 0.0% |
2017 | - EUR | 0.0% |
2016 | - EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 Q2 | -489 Thousand EUR | 0.0% |
2023 Q3 | 1.00 EUR | 100.0% |
2023 Q1 | - EUR | 100.0% |
2023 FY | 1.00 EUR | 100.0% |
2023 Q4 | 1.00 EUR | 0.0% |
2022 Q1 | - EUR | -100.0% |
2022 Q2 | 2.26 Million EUR | 0.0% |
2022 Q3 | - EUR | -100.0% |
2022 FY | -469 Thousand EUR | 0.0% |
2022 Q4 | -469 Thousand EUR | 0.0% |
2021 Q1 | 1.00 EUR | 0.0% |
2021 FY | - EUR | -100.0% |
2021 Q4 | 295 Thousand EUR | 0.0% |
2021 Q3 | - EUR | -100.0% |
2021 Q2 | 2.13 Million EUR | 213299900.0% |
2020 Q4 | 1.00 EUR | 0.0% |
2020 Q3 | 1.00 EUR | -100.0% |
2020 Q1 | 1.00 EUR | 0.0% |
2020 FY | 1.00 EUR | -100.0% |
2020 Q2 | 2.22 Million EUR | 222799900.0% |
2019 Q3 | - EUR | 0.0% |
2019 Q4 | - EUR | 0.0% |
2019 FY | 3.2 Million EUR | 220.96% |
2019 Q1 | - EUR | 0.0% |
2018 FY | 997 Thousand EUR | 0.0% |
2017 FY | - EUR | 0.0% |
2016 FY | - EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
ABIONYX Pharma SA | 221 Thousand EUR | 100.0% |
ABIVAX Société Anonyme | 1.00 EUR | 0.0% |
Adocia SA | 272 Thousand EUR | 100.0% |
Aelis Farma SA | 53 Thousand EUR | 99.998% |
Biophytis S.A. | - EUR | -Infinity% |
Advicenne S.A. | 1.74 Million EUR | 100.0% |
genOway Société anonyme | 982.75 Thousand EUR | 100.0% |
IntegraGen SA | 311.44 Thousand EUR | 100.0% |
Medesis Pharma S.A. | 164.62 Thousand EUR | 99.999% |
Neovacs S.A. | - EUR | -Infinity% |
NFL Biosciences SA | -1.1 Million EUR | 100.0% |
Plant Advanced Technologies SA | 1.22 Million EUR | 100.0% |
Quantum Genomics Société Anonyme | -119.17 Thousand EUR | 100.001% |
Sensorion SA | - EUR | -Infinity% |
Theranexus Société Anonyme | - EUR | -Infinity% |
TME Pharma N.V. | 91 Thousand EUR | 99.999% |
Valbiotis SA | 1 Million EUR | 100.0% |
TheraVet SA | 123.34 Thousand EUR | 99.999% |
Valerio Therapeutics Société anonyme | 1.00 EUR | 0.0% |
argenx SE | 281.12 Million EUR | 100.0% |
BioSenic S.A. | - EUR | -Infinity% |
Celyad Oncology SA | 1.26 Million EUR | 100.0% |
DBV Technologies S.A. | 1.00 USD | 0.0% |
Galapagos NV | 73.97 Million EUR | 100.0% |
Genfit S.A. | 4000.00 EUR | 99.975% |
GeNeuro SA | - EUR | -Infinity% |
Innate Pharma S.A. | 1.00 EUR | 0.0% |
Inventiva S.A. | 417 Thousand EUR | 100.0% |
MaaT Pharma SA | 190 Thousand EUR | 99.999% |
MedinCell S.A. | -6.71 Million EUR | 100.0% |
Nanobiotix S.A. | 200 Thousand EUR | 100.0% |
Onward Medical N.V. | 936 Thousand EUR | 100.0% |
Oryzon Genomics S.A. | 6029.00 EUR | 99.983% |
OSE Immunotherapeutics SA | - EUR | -Infinity% |
Oxurion NV | 128 Thousand EUR | 99.999% |
Pharming Group N.V. | 51.38 Million EUR | 100.0% |
Poxel S.A. | 2.95 Million EUR | 100.0% |
GenSight Biologics S.A. | 1.00 EUR | 0.0% |
Transgene SA | - EUR | -Infinity% |
Financière de Tubize SA | - EUR | -Infinity% |
UCB SA | 1.03 Billion EUR | 100.0% |
Valneva SE | 44.46 Million EUR | 100.0% |
Vivoryon Therapeutics N.V. | 1.00 EUR | 0.0% |